Lung Cancer

Early Study Results Show Novel Combo Therapy May Be Effective in Lung Cancer Subtype

July 14, 2021

The preliminary results of an early-phase study of rigosertib combined with nivolumab for the treatment of advanced metastatic KRAS-mutated non-small cell lung cancer are scheduled to be presented at an upcoming medical conference.

FDA Grants Sintilimab/Pemetrexed Review for Frontline Nonsquamous NSCLC

May 19, 2021

A biologics license application for sintilimab injection plus pemetrexed and platinum-based chemotherapy for the frontline treatment of patients with nonsquamous non–small cell lung cancer has been accepted for FDA review.